Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gynecology

  Free Subscription

12.02.2024

1 Acta Obstet Gynecol Scand
2 Anticancer Res
1 Aust N Z J Obstet Gynaecol
2 BMC Cancer
1 Br J Cancer
1 Cancer
2 Eur J Cancer
7 Eur J Obstet Gynecol Reprod Biol
8 Fertil Steril
11 Gynecol Oncol
3 Hum Reprod
1 Int J Cancer
7 Int J Gynaecol Obstet
6 JAMA
2 Lancet
3 Obstet Gynecol
3 PLoS One



    Acta Obstet Gynecol Scand


  1. Correction to "Intravaginal electrical stimulation: A randomized, double-blind study on the treatment of mixed urinary incontinence".
    Acta Obstet Gynecol Scand. 2024 Feb 5. doi: 10.1111/aogs.14782.
    >> Share


    Anticancer Res

  2. LEE O, Yoon SK, Yoon SJ, Kim H, et al
    Pancreatic Metastasectomy for Secondary Malignancy of the Pancreas: A Single-institution Experience.
    Anticancer Res. 2024;44:703-710.
    >> Share

  3. KIM Y, Ajiki T, Ueda Y, Yoshida Y, et al
    Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
    Anticancer Res. 2024;44:613-619.
    >> Share


    Aust N Z J Obstet Gynaecol

  4. BOO M, Simcock B, Sykes P, Brand A, et al
    Direct oral anticoagulants (DOACs) use for prolonged venous thromboembolism prophylaxis following surgery for gynaecological malignancies in Australia and New Zealand - A clinician survey.
    Aust N Z J Obstet Gynaecol. 2024;64:36-41.
    >> Share


    BMC Cancer

  5. JAMALZADEH S, Dai J, Lavikka K, Li Y, et al
    Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma.
    BMC Cancer. 2024;24:173.
    >> Share

  6. XIAO L, Dong X, Sun J, Zhang X, et al
    Focused ultrasound versus the loop electrosurgical excision procedure to treat women with cervical high-grade squamous intraepithelial lesions under 40: a retrospective study.
    BMC Cancer. 2024;24:169.
    >> Share


    Br J Cancer

  7. POSTEL-VINAY S, Coves J, Texier M, Aldea M, et al
    Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
    Br J Cancer. 2023 Dec 14. doi: 10.1038/s41416-023-02514.
    >> Share


    Cancer

  8. PARK S, Kim YJ, Min YJ, Mortimer PGS, et al
    Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
    Cancer. 2023 Oct 16. doi: 10.1002/cncr.35059.
    >> Share


    Eur J Cancer

  9. LINDEMANN K, Kildal W, Kleppe A, Tobin KAR, et al
    Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.
    Eur J Cancer. 2024;200:113584.
    >> Share

  10. MATSUO K, Chen L, Neuman MK, Klar M, et al
    Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy.
    Eur J Cancer. 2024;200:113533.
    >> Share


    Eur J Obstet Gynecol Reprod Biol

  11. SHIBAHARA M, Kurita T, Harada H, Tsuda Y, et al
    Therapeutic management of uterine tumours resembling ovarian sex cord tumours including a focus on fertility: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2024;295:1-7.
    >> Share

  12. DALL'ASTA A, Frusca T, Rizzo G, Ramirez Zegarra R, et al
    Assessment of the cerebroplacental ratio and uterine arteries in low-risk pregnancies in early labour for the prediction of obstetric and neonatal outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2024;295:18-24.
    >> Share

  13. BRUYNS L, Colson A, Ryckoort V, Steenhaut P, et al
    Pregnancy outcome in patients with Ehlers-Danlos Syndrome after cervical cerclage.
    Eur J Obstet Gynecol Reprod Biol. 2024 Jan 24:S0301-2115(24)00034.
    >> Share

  14. PUSCHL IC, Thaneswaran Vyramuthu M, Bonde L, Lebech M, et al
    Is salivary uric acid, a putative biomarker of pre-eclampsia, of maternal, placental, or fetal origin?
    Eur J Obstet Gynecol Reprod Biol. 2024;295:34-41.
    >> Share

  15. WEI D, Luo C, Chen Y, Li J, et al
    A large sample-based case-control study of related risk factors of two types of lichenoid vulvar disease (LVD).
    Eur J Obstet Gynecol Reprod Biol. 2024;293:15-20.
    >> Share

  16. PORCU-BUISSON G, Maignien C, Swierkowski-Blanchard N, Rongieres C, et al
    Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF/ICSI procedures (DELTA Study).
    Eur J Obstet Gynecol Reprod Biol. 2024;293:21-26.
    >> Share

  17. DEBRAS E, Jegaden M, Pourcelot AG, Capmas P, et al
    Indigo carmine dye for detecting urinary track damage during vaginal surgery.
    Eur J Obstet Gynecol Reprod Biol. 2024;293:142-145.
    >> Share


    Fertil Steril

  18. CARVALHO BR, Cintra GF, Cabral IO, Franceschi TM, et al
    First pregnancy and live birth from ex vivo retrieved MII oocytes from a woman with bilateral ovarian carcinoma: case report.
    Fertil Steril. 2024 Feb 3:S0015-0282(24)00077.
    >> Share

  19. ABDUL LATIF NFB, Guan Z, Asare S, Guan X, et al
    Robotic-Assisted Single-Site Abdominal Cerclage in the Bicornuate Uterus Patient with Cervical Insufficiency.
    Fertil Steril. 2024 Feb 3:S0015-0282(24)00076.
    >> Share


  20. Family members as gamete donors or gestational carriers: an Ethics Committee opinion.
    Fertil Steril. 2024 Feb 6:S0015-0282(24)00010.
    >> Share

  21. BAKKENSEN JB, Strom D, Boots CE
    Frozen embryo transfer outcomes decline with increasing female body mass index in female but not male factor infertility: analysis of 56,564 euploid blastocyst transfers.
    Fertil Steril. 2024;121:271-280.
    >> Share

  22. TANG Y, Mui J, Tsai B, Storness-Bliss C, et al
    Bliss procedure for undescended ovaries.
    Fertil Steril. 2024;121:353-354.
    >> Share

  23. PALOMBA S
    The progression of intensity and complexity of treatment as a cornerstone of the management of polycystic ovary syndrome-related infertility.
    Fertil Steril. 2024;121:252-253.
    >> Share

  24. BUSSIES P, Sweterlitsch KM, Richards EG
    Elegance is bliss: a novel approach to treating undescended ovaries in select patients with primary infertility.
    Fertil Steril. 2024;121:258.
    >> Share

  25. GIBBONS T, Rahmioglu N, Zondervan KT, Becker CM, et al
    Crimson clues: advancing endometriosis detection and management with novel blood biomarkers.
    Fertil Steril. 2024;121:145-163.
    >> Share


    Gynecol Oncol

  26. AROCHE GUTIERREZ LL, McIntire DD, Lea J, LoCoco S, et al
    Social determinants of health in uterine carcinosarcoma.
    Gynecol Oncol. 2024;184:117-122.
    >> Share

  27. HARI A, Chang J, Villanueva C, Ziogas A, et al
    Short-term survival analysis of a risk-adjusted model for ovarian cancer care.
    Gynecol Oncol. 2024;184:123-131.
    >> Share

  28. YOON H, Suh DH, Kim K, No JH, et al
    Evaluation of prognostic potential of beta-catenin and L1CAM expression according to endometrial cancer risk group.
    Gynecol Oncol. 2024;184:132-138.
    >> Share

  29. TELLES R, Zimmerman MB, Thaker PH, Slavich GM, et al
    Rural-urban disparities in psychosocial functioning in epithelial ovarian cancer patients.
    Gynecol Oncol. 2024;184:139-145.
    >> Share

  30. LEITAO MM JR
    2023 changes to FIGO endometrial cancer staging: Counterpoint.
    Gynecol Oncol. 2024;184:146-149.
    >> Share

  31. ROSATO R, Ferrero A, Mosconi P, Ciccone G, et al
    Impact of different follow-up regimens on health-related quality of life and costs in endometrial cancer patients: Results from the TOTEM randomized trial.
    Gynecol Oncol. 2024;184:150-159.
    >> Share

  32. SMITH AJB, Gleason EG, Andriani L, Heintz J, et al
    Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?
    Gynecol Oncol. 2024;184:160-167.
    >> Share

  33. POTHURI B, Han S, Chase DM, Heitz F, et al
    Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
    Gynecol Oncol. 2024;184:168-177.
    >> Share

  34. LEVINE MD, Wagner VM, Riedinger CJ, Khadraoui W, et al
    Authentic leadership in action: Experience gained from a gynecologic oncology fellowship leadership curriculum.
    Gynecol Oncol. 2024;182:176-178.
    >> Share

  35. STEVENTON L, Nicum S, Man K, Chaichana U, et al
    A systematic review of ethnic minority participation in randomised controlled trials of systemic therapies for gynecological cancers.
    Gynecol Oncol. 2024;184:178-189.
    >> Share

  36. SOMASEGAR S, Reddy RA, Chow S, Dorigo O, et al
    Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysis.
    Gynecol Oncol. 2024;184:190-197.
    >> Share


    Hum Reprod

  37. MIQUEL L, Liotta J, Pivano A, Gnisci A, et al
    Ethanol endometrioma sclerotherapy: safety through 8 years of experience.
    Hum Reprod. 2024 Feb 7:deae014. doi: 10.1093.
    >> Share

  38. FENG S, Wang B, Chen S, Xie Q, et al
    Association between proliferative-to-secretory endometrial compaction and pregnancy outcomes after embryo transfer: a systematic review and meta-analysis.
    Hum Reprod. 2024 Feb 7:deae012. doi: 10.1093.
    >> Share

  39. TONG F, Wang Y, Gao Q, Zhao Y, et al
    The epidemiology of pregnancy loss: global burden, variable risk factors, and predictions.
    Hum Reprod. 2024 Feb 2:deae008. doi: 10.1093.
    >> Share


    Int J Cancer

  40. TANG T, Yu H, Xu S, Zhong Y, et al
    Causal effects of endometriosis on cancer risk: A Mendelian randomization study.
    Int J Cancer. 2024 Feb 7. doi: 10.1002/ijc.34876.
    >> Share


    Int J Gynaecol Obstet

  41. AMIKAM U, Badeghiesh A, Baghlaf H, Brown R, et al
    Transient ischemic attack and pregnancy, delivery and neonatal outcomes-An evaluation of a population database.
    Int J Gynaecol Obstet. 2024 Feb 4. doi: 10.1002/ijgo.15387.
    >> Share

  42. LEVIN G, Brezinov Y, Tzur Y, Meyer R, et al
    Open access transition in obstetrics and gynecology journals-The international impact.
    Int J Gynaecol Obstet. 2024 Feb 4. doi: 10.1002/ijgo.15398.
    >> Share

  43. PEREZ BARRIOS E, Diaz-Valdes A
    An exploratory study of the factors associated with use of contraceptive methods in young Chilean women aged 17-29 years.
    Int J Gynaecol Obstet. 2024 Feb 5. doi: 10.1002/ijgo.15408.
    >> Share

  44. ILYAS U, Tariq Z, Asim J, Arshad Z, et al
    Experiential avoidance, thought suppression, meta-cognition, and body-checking among women during pregnancy and postpartum: Buffering effect of self-compassion.
    Int J Gynaecol Obstet. 2024 Feb 5. doi: 10.1002/ijgo.15400.
    >> Share

  45. ETRUSCO A, Lagana AS, Chiantera V, Gerli S, et al
    Efficacy, safety, and feasibility of the treatment of intrauterine pathologies with the mini-resectoscope: A systematic review.
    Int J Gynaecol Obstet. 2024 Feb 5. doi: 10.1002/ijgo.15393.
    >> Share

  46. ROBIJN AL, Harvey SM, Jensen ME, Atkins S, et al
    Adverse neonatal outcomes in pregnant women with asthma: An updated systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2024 Feb 7. doi: 10.1002/ijgo.15407.
    >> Share

  47. LAPORTE M, Marcelino AC, da Cunha Pereira P, Espejo-Arce X, et al
    Effectiveness and continuation rates of the etonogestrel-subdermal contraceptive implant versus short-acting contraceptive methods offered at no cost in Campinas, Brazil.
    Int J Gynaecol Obstet. 2024 Feb 8. doi: 10.1002/ijgo.15415.
    >> Share


    JAMA

  48. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    >> Share

  49. HORVATH S, Schreiber CA, Luning Prak ET
    Rh Sensitization and Induced Abortion-Reply.
    JAMA. 2024;331:445-446.
    >> Share

  50. MOISE KJ JR, Abels EA
    Rh Sensitization and Induced Abortion.
    JAMA. 2024;331:444.
    >> Share

  51. GALEN RS, Kaufman HW, Evans MI
    Rh Sensitization and Induced Abortion.
    JAMA. 2024;331:444-445.
    >> Share

  52. UZOIGWE CE, Ali O
    Rh Sensitization and Induced Abortion.
    JAMA. 2024;331:443-444.
    >> Share

  53. HARRIS E
    65?000 Rape-Related Pregnancies Took Place in US States With Abortion Bans.
    JAMA. 2024 Feb 7. doi: 10.1001/jama.2024.0177.
    >> Share


    Lancet

  54. LUCAS N, Rex S, Devroe S
    Treatment modalities for placenta accreta spectrum.
    Lancet. 2024;403:437.
    >> Share

  55. MORLEY LC, Sparey C, Wijeratne D, Turner K, et al
    Treatment modalities for placenta accreta spectrum - Authors' reply.
    Lancet. 2024;403:437-438.
    >> Share


    Obstet Gynecol

  56. FELDMAN KM, Coughlin A, Feliciano J, Stoffels G, et al
    Neonatal Birth Weight With Daily Compared With Every-Other-Day Glucose Monitoring in Gestational Diabetes Mellitus: A Randomized Controlled Trial.
    Obstet Gynecol. 2024 Feb 8. doi: 10.1097/AOG.0000000000005528.
    >> Share

  57. HORGAN R, Hughes BL, Waller J, Hage Diab Y, et al
    Understanding New Recommendations for Respiratory Syncytial Virus Prevention in Pregnancy.
    Obstet Gynecol. 2024 Feb 8. doi: 10.1097/AOG.0000000000005524.
    >> Share

  58. GILL S, Anderson M, Neveu J
    Endometrial Cancer in a Transgender Man with Prolonged Exogenous Testosterone Use.
    Obstet Gynecol. 2024 Feb 8. doi: 10.1097/AOG.0000000000005527.
    >> Share


    PLoS One

  59. ROBBINS SJ, Brown SE, Stennett CA, Tuddenham S, et al
    Uterine fibroids and longitudinal profiles of the vaginal microbiota in a cohort presenting for transvaginal ultrasound.
    PLoS One. 2024;19:e0296346.
    >> Share

  60. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    >> Share

  61. YONG CM, Yehgambaram PAP, Lee SWH
    Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia.
    PLoS One. 2024;19:e0298130.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016